In particular, 1 patient (0.7%) showed a biochemical status of active acromegaly with both elevated IGF1 levels (IGF1 + 5.61 SDS) and lack of GH suppression after OGTT (GH nadir 1.27 μg/L) 15 months after surgery. This evidence concerns the gene IGF1 and acromegaly.